InsiderTrades

Form 4 for PBH Prestige Consumer Healthcare Inc.

Accepted 2022-11-21 00:00:00 ET · period of report 2022-11-18 · accession 0001104659-22-120742 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-11-21 2022-11-18 PBH Lombardi Ronald M. CEO, Dir M - OptEx $29.94 +38.8K 260.6K +17% +$1.16M
D 2022-11-21 2022-11-18 PBH Lombardi Ronald M. CEO, Dir S - Sale+OE $59.10 -38.8K 221.8K -15% -$2.29M
D 2022-11-21 2022-11-18 PBH Lombardi Ronald M. CEO, Dir M - OptEx $0.00 -38.8K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.01 per share 2022-11-18 M A 38,793 $29.94 260,613 D — —
2 Common Common Stock, par value $0.01 per share 2022-11-18 S D 38,793 $59.10 221,820 D — — (F1) Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $58.69 to $59.75.
3 Derivative Employee Stock Options (right to buy) 2022-11-18 M D 38,793 $0.00 0 D $29.94 · — to 2023-05-14 38,793 Common Stock (F2) The options vested 12,931 on each of May 14, 2014, 2015 and 2016.